Academic cytopathology

Pathology

Ruth Katz works in the field of Pathology. Ruth L. Katz, MD is a published physician as well. He has 50 publications published. The latest was: Leptomeningeal disease and breast cancer: the importance of tumor subtype. He accepts all Medicare patients.

Publications

---

• Leptomeningeal disease and breast cancer: the importance of tumor subtype.
• Cervista HPV assays for fine-needle aspiration specimens are a valid option for human papillomavirus testing in patients with oropharyngeal carcinoma.
• Fine-needle aspiration diagnosis of lymphomas with signet ring cell features: Potential pitfalls and solutions.
• Two birds with one stone: octreotide treatment for acromegaly and breast cancer.
• Use of fluorescence in situ hybridization to predict response to bacillus Calmette-Guérin therapy for bladder cancer: results of a prospective trial.
• Dasatinib-Responsive Mast Cell Neoplasms As Initial Presentation of Chronic Myelogenous Leukemia in Blast Phase.
• Expression and Relevance of TRPS-1: A New GATA Transcription Factor in Breast Cancer.
• Plasma microRNAs as potential biomarkers for non-small-cell lung cancer.
• Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers.
• Computerized analysis of cytology and fluorescence in situ hybridization (FISH) in induced sputum for lung cancer detection.
• Fluorescence in situ hybridization for detecting urothelial carcinoma: a clinicopathologic study.
• A review on the current state of urine cytology emphasizing the role of fluorescence in situ hybridization as an adjunct to diagnosis.
• Genetically abnormal circulating cells in lung cancer patients: an antigen-independent fluorescence in situ hybridization-based case-control study.
• Radioactive iodine-associated changes in thyroid on fine-needle aspiration.
• Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer.
• Chromosomal abnormalities detected by multicolor fluorescence in situ hybridization in fine-needle aspirates from patients with small lymphocytic lymphoma are useful f...
• Quantitation of Aurora kinase A gene copy number in urine sediments and bladder cancer detection.
• 3p22.1 and 10q22.3 deletions detected by fluorescence in situ hybridization (FISH): a potential new tool for early detection of non-small cell lung Cancer (NSCLC).
• Magnetic enrichment of bronchial epithelial cells from sputum for lung cancer diagnosis.
• Automated detection of genetic abnormalities combined with cytology in sputum is a sensitive predictor of lung cancer.
• Gain of the 3q26 region in cervicovaginal liquid-based pap preparations is associated with squamous intraepithelial lesions and squamous cell carcinoma.
• Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancer.
• Combination of cytologic evaluation and quantitative digital cytometry is reliable in detecting recurrent disease in patients with urinary diversions.
• Fine-needle aspiration biopsy findings in patients with small lymphocytic lymphoma transformed to hodgkin lymphoma.
• Up-regulation of 14-3-3zeta in lung cancer and its implication as prognostic and therapeutic target.
• Genetic deletions in sputum as diagnostic markers for early detection of stage I non-small cell lung cancer.
• Fungal fruiting bodies in a Pap smear: contamination or infection?
• Modern approach to lymphoma diagnosis by fine-needle aspiration: restoring respect to a valuable procedure.
• High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-...
• Overexpression of S100A2 protein as a prognostic marker for patients with stage I non small cell lung cancer.
• Surfactant protein A gene deletion and prognostics for patients with stage I non-small cell lung cancer.
• Cytologic features of renal medullary carcinoma.
• Comparison of molecular abnormalities in bronchial brushings and tumor touch preparations.
• Expression of PAX5 in CD20-positive multiple myeloma assessed by immunohistochemistry and oligonucleotide microarray.
• Genomic profiles in stage I primary non small cell lung cancer using comparative genomic hybridization analysis of cDNA microarrays.
• Evaluation of peripheral blood involvement of mantle cell lymphoma by fluorescence in situ hybridization in comparison with immunophenotypic and morphologic findings.
• Case 69: extramedullary hematopoiesis.
• Grading follicular lymphoma on fine needle aspiration specimens. Comparison with proliferative index by DNA image analysis and Ki-67 labeling index.
• Evaluation of interphase fluorescence in situ hybridization for the t(14;18)(q32;q21) translocation in the diagnosis of follicular lymphoma on fine-needle aspirates: a...
• Nonablative allogeneic stem-cell transplantation for advanced/recurrent mantle-cell lymphoma.
• Cytomorphologic spectrum of small lymphocytic lymphoma in patients with an accelerated clinical course.
• Centrosomal abnormality is common in and a potential biomarker for bladder cancer.
• Detection of a subset of CD30+ anaplastic large cell lymphoma by interphase fluorescence in situ hybridization.
• Comparison of quantification of histochemical staining by hue-saturation-intensity (HSI) transformation and color-deconvolution.
• Amplification/overexpression of a mitotic kinase gene in human bladder cancer.
• Rapid detection of IgH/BCL2 rearrangement in follicular lymphoma by interphase fluorescence in situ hybridization with bacterial artificial chromosome probes.
• Discrepancies in the immunophenotype of lymphoma cells in samples obtained simultaneously from different anatomic sites.
• Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells.
• Use of interphase fluorescence in situ hybridization as a powerful diagnostic tool in cytology.

Schools

---

• University Of The Witwatersrand Medical School

• Edenvale

• New Eng Med Center

• MD Anderson Canc Center

Doctors Specialties

---

• Cytopathology
• Pathology

Accepted Insurances

---

• Choice Plus POS II
• CHAMPVA
• Cigna HMO
• Cigna PPO
• Great West Healthcare-Cigna PPO
• LocalPlus
• Open Access Plus
• Commercial Insurance Company
• Coventry Health Care
• Emblem Health
• First Health (Coventry Health Care) PPO
• GEHA
• Medicare Advantage PFFS
• Humana
• Mail Handlers Benefit Plan (MHBP)
• Medicare MCR
• Choice Plus POS
• Navigate HMO
• Navigate POS
• Options PPO
• United Healthcare

Education

---

• University of Texas Health Science Center
• Tufts Medical Center
• University of the Witwatersrand

Hospital

---

• University of Texas M.D. Anderson Cancer Center

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Mary R. Schwartz, MD This Doctor is OpenDoctor Recommended.
	Dr. John L. Stavinoha Jr., MD This Doctor is OpenDoctor Recommended.
	Dr. Rose C. Anton, MD This Doctor is OpenDoctor Recommended.
	Dr. Deborah R. Citron, MD This Doctor is OpenDoctor Recommended.
	Dr. Neda Kalhor, MD This Doctor is OpenDoctor Recommended.
	Dr. Lee A. Grossberg, MD
	Dr. Ena E. Mocega, MD This Doctor is OpenDoctor Recommended.
	Dr. Regina R. Verani, MD This Doctor is OpenDoctor Recommended.
	Dr. Ying Ye, MD
	Dr. Ross A. Miller, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog